Analyst
Ahsan Zahid
ahsan.zahid@pacra.com
+92-42-35869504
www.pacra.com
Applicable Criteria
Related Research
PACRA Assigns Initial Ratings to Ismail Industries Limited - PPSTS-5 - PKR 8bln - Aug-25
| Rating Type | Debt Instrument | |
|
Current (05-Dec-25 ) |
||
| Action | Initial | |
| Long Term | AA- | |
| Short Term | A1 | |
| Outlook | Stable | |
| Rating Watch | - | |
The assigned ratings of Ismail Industries Limited (“IIL” or “the Company”) reflect its entrenched market position, resilient operational dynamics, and demonstrated capacity to diversify and innovate within its core business segments. During FY25, approximately ~66% of total revenue emanated from domestic operations, while exports accounted for the remaining ~34% (FY24: 55%, 45%, respectively). The rise in domestic sales is mainly attributable to the World Food Programme’s (WFP) initiative, which strategically reallocated a portion of export-oriented food products towards local consumption. The ratings incorporate IIL’s sustained business growth, underpinned by prudent financial management and sound liquidity buffers. The Company’s expanding footprint is primarily driven by higher volumetric sales in the domestic market and the successful rollout of new product lines. During the year, IIL infused 100% equity amounting to USD 10 million into a newly incorporated foreign subsidiary, Bisconni Middle East Manufacturing LLC, based in Abu Dhabi, UAE. This strategic investment aims to capture the rising demand within the middle east region’s biscuit segment. IIL’s diversified brand portfolio comprising Candyland, Bisconni, SnackCity, Ismail Nutrition, Ghiza Flour, and Astro Films continue to anchor revenue stability. The Company maintains notable strategic investments in subsidiaries and associates, reflecting its commitment to diversification and vertical integration. These include a ~78.53% stake in Hudson Pharma (Pvt.) Limited, engaged in the production of inhalation solutions, ophthalmic drops, intravenous infusions, and topical formulations, and a ~75% holding in Ismail Resin (Pvt.) Limited, enabling vertical integration through PET resin manufacturing. Financially, IIL reported a marginal contraction in gross margins to 20.8% (FY24: 22.1%) on account of moderated topline erosion. However, the Company successfully sustained its net margin at 5.5% (FY24: 5.6%), primarily supported by a substantial decline in finance costs, reflecting improved financial discipline. Recognizing the inherent challenges in the confectionery sector, such as evolving consumer preferences and a heightened focus on health-conscious consumption, the Company continues to emphasize product innovation, including the launch of premium variants aimed at strengthening margin sustainability.
The ratings are dependent on sustained revenue growth, margin maintenance, and prudent financial management. Prioritizing brand reputation and disciplined debt management are crucial for maintaining the ratings.
About
the Entity
Ismail Industries Limited, incorporated in 1988, is a public listed Company. Principal activities of the Company are manufacturing and trading of sugar confectionery items, biscuits, nutritional products, flour, cast polypropylene films under the brands of 'CandyLand', 'Bisconni', 'SnackCity', 'Ismail Nutrition', Ghiza', 'Super Cereal' and 'Astro Films' respectively. Major shareholding of the Company lies with Ismail Family (~99%), through Mr. Muhammad Ismail (~15.7%), Ms. Almas Maqsood, wife of Mr. Maqsood Ismail, (~29.8%), Mr. Miftah Ismail (~31.0%), Mr. Ahmed Muhammad (~15.2%) and associates (~0.7%) along with free float. Mr. Muhammad Ismail is the Chairman of the Board. The CEO, Mr. Munsarim Saifullah, is supported by an experienced management team.
About
the Instrument
The Company has issued its 5th rated, privately placed, unsecured short-term Sukuk amounting to PKR 8,000 million inclusive of a PKR 3 billion green-shoe option, in August 2025 to finance its working capital requirements. This issuance replaces the previously issued PPSTS of PKR 8 billion that matured on August 18, 2025. The instrument carries a tenor of six months and offers a profit rate of 3MK minus 5 basis points, with both profit and principal payable in full at maturity.